Sudarshan Pharma Industries IPOSudarshan Pharma Industries IPO Analysis at,
    the Oldest & the most Trusted Investment Blog in India. Operational since 8th December 1999, this is the Only Investment Platform in India, which has successfully completed 23 Years.

    Sudarshan Pharma Industries IPO


    Sudarshan Pharma Industries IPO Grey Market updates 
    For latest updates, Click

    Sudarshan Pharma IPO Subscription Status
    On 14 March 2023 @ 5.00 pm (Closed)
    QIB:      3259200 Shares,  1.01T
    NII:       977760   Shares,  0.81T
    RII:        2281440 Shares,  1.20T
    Total:    6518400 Shares   1.06T

    Sudarshan Pharma Industries: Company Details

    Core business is manufacturing of Specialty Chemicals & Intermediates for Pharma, agro chemicals, Coating, paints, adhesive and various other industries. It is also into Active Pharmaceuticals Ingredients manufacturing. Some products it outsources and manufacturers at its toll manufacturing facility, it is also into specialty chemicals imports & exports as well as supply of same to the actual users. As per the clients need and requirements, it provides customize specialty chemicals to its clients in India and abroad regularly. Its Specialty chemicals & its Intermediates have wide application in sectors like pharma, agro chemicals, performance chemicals, resins, paint, food, adhesive and various other Industries.

    The company is also involved in Contract Manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals.
    It carries about Ethical marketing of pharmaceutical formulation & products in the Domestic and International market through its own distribution network and Sales force under its own brands. Its Pharma & Specialty Chemical business operations are supported by various manufacturers having facilities which are approved by the FDA, WHO and other relevant authorities. It typically enters into contract manufacturing agreements for periods ranging from one to three years with the manufacturer of Pharma products.

    For more information about the company, Click

    Sudarshan Pharma Industries IPO Details
    IPO opens on Tentative  9 March 2023
    IPO closes on   14   March 2023
    Issue Type Book Built Issue IPO
    Issue Size 6862400 Sh /Rs 50.10 Cr
    * Fresh Issue 6862400 Sh /Rs 50.10 Cr
    * Offer for Sale  – Sh /Rs – Cr
    Face Value per share: Rs. 10
    Price Band Rs.71-73
    Employee discount  Rs. 0 per share
    Retail Lot Size  1600 Shares
    Listing will at  BSE Sme
    Shares offered to
      Shares Rs. (Cr)
    QIB (50 %)  3259200 23.79
    NII (15 %)  977760 7.14
    RII (35 %) 2281440 16.65
    Total Shares  6518400 47.58
    Retail portion will be oversubscribed by  1426
    How much Shares to Apply?
    Min Retail Application 1600 Sh Rs. 116800
    Max Retail Application  3200 Sh Rs. 233600

    Promoters of the IPO

    Objects of the IPO:
    The Company proposes to utilize the Net Proceeds from the Issue towards
    Funding the working capital requirements

    IPO Tentative timetable
    IPO opens on 9   March 2023
    IPO Closes on 14   March 2023
    IPO Allotment on  16 March 2023
    Unblocking of ASBA  17 March 2023
    Credit of Shares 20 March 2023
    Listing on 21 March 2023
    Registered Office of the Company
    301,3rd Floor, Aura Biplex, Above Kalyan
    Jewellers S. V. Road, Borivali (West)
    Mumbai City Maharashtra 400092 India.
    IPO Lead Managers 
    Registrar to the IPO
    IPO Financial & Analytical Ratios
    Year Total Income Net Profit EPS RoNW Cr Cr Rs. %
    2019-20 148.00 1.28 1.34 6.43
    2020-21 193.73 2.67 2.80 11.87
    2021-22  357.56 5.30 5.52 17.81
    Book Value of the Share on 31.03.2022 Rs.19.23    
    Book Value of the Share after the IPO Rs.40.65    
    Offer Price   Rs. 73    
    Ratio Analysis
    Upper Price/last EPS 13.22
    Upper price/BV Ratio 3.80
    Upper price/BV after IPO  1.80

    Sudarshan Pharma Industries IPO Peer Comparison: 

    As on date of RHP FV Total  PE
      Rs. Income Ratio of
        Rs. In Cr  
    The IPO Company 10 355.47 13.22
    Eris Life Science 10 282.14 89.11
    Sigachi Industries  10 70.87 64.79
    Aarti Drugs 10 551.20 63.68


    # This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.

    >>Go to Mainboard IPOs Section: Click
    >>Get Good Staff or Job, Click:
    >>Interested in Used Automobiles or vintage cars? Click:
    >>Get solid Guidance on Mutual fund Investments, Click:
    >>Study Stock Research Reports, Click:
    Interested in Crossword Puzzles? Click:

    Leave a Reply

    Your email address will not be published. Required fields are marked *